CA2578845A1 - Comprimes multicouche et formes posologiques bioadhesives - Google Patents

Comprimes multicouche et formes posologiques bioadhesives Download PDF

Info

Publication number
CA2578845A1
CA2578845A1 CA002578845A CA2578845A CA2578845A1 CA 2578845 A1 CA2578845 A1 CA 2578845A1 CA 002578845 A CA002578845 A CA 002578845A CA 2578845 A CA2578845 A CA 2578845A CA 2578845 A1 CA2578845 A1 CA 2578845A1
Authority
CA
Canada
Prior art keywords
tablet
drug
bioadhesive
layer
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002578845A
Other languages
English (en)
Inventor
Avinash Nangia
Jules Jacob
Edith Mathiowitz
Thomas L. Ricketts
Mark R. Kreitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spherics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/009,327 external-priority patent/US20050201974A1/en
Priority claimed from PCT/US2005/007525 external-priority patent/WO2005084639A2/fr
Application filed by Individual filed Critical Individual
Publication of CA2578845A1 publication Critical patent/CA2578845A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA002578845A 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives Abandoned CA2578845A1 (fr)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US60519904P 2004-08-27 2004-08-27
US60520104P 2004-08-27 2004-08-27
US60519804P 2004-08-27 2004-08-27
US60499004P 2004-08-27 2004-08-27
US60520004P 2004-08-27 2004-08-27
US60499104P 2004-08-27 2004-08-27
US60/605201 2004-08-27
US60/605200 2004-08-27
US60/604991 2004-08-27
US60/605199 2004-08-27
US60/604990 2004-08-27
US60/605198 2004-08-27
US60790504P 2004-09-08 2004-09-08
US60/607905 2004-09-08
US11/009,327 2004-12-09
US11/009,327 US20050201974A1 (en) 2003-12-09 2004-12-09 Bioadhesive polymers with catechol functionality
US63581204P 2004-12-13 2004-12-13
US60/635812 2004-12-13
US65019105P 2005-02-04 2005-02-04
US65037505P 2005-02-04 2005-02-04
US60/650375 2005-02-04
US60/650191 2005-02-04
USPCT/US2005/007525 2005-03-03
PCT/US2005/007525 WO2005084639A2 (fr) 2004-03-03 2005-03-03 Systeme d'administration de medicaments polymeres pour des medicaments hydrophobes
US67638305P 2005-04-29 2005-04-29
US60/676383 2005-04-29
PCT/US2005/030651 WO2006031420A2 (fr) 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives

Publications (1)

Publication Number Publication Date
CA2578845A1 true CA2578845A1 (fr) 2006-03-23

Family

ID=35703299

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002578845A Abandoned CA2578845A1 (fr) 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives

Country Status (4)

Country Link
EP (1) EP1784167A2 (fr)
AU (1) AU2005285298A1 (fr)
CA (1) CA2578845A1 (fr)
WO (1) WO2006031420A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2086515A2 (fr) * 2006-03-02 2009-08-12 Vaunnex, Inc. Formulations bioadhésives posologiques orales a liberation controlee
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US8974825B2 (en) 2007-07-06 2015-03-10 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP3620153A1 (fr) 2007-07-06 2020-03-11 Lupin Limited Compositions pharmaceutiques pour administration gastro-intestinale de médicaments
JP2013169146A (ja) * 2012-02-17 2013-09-02 Kabaya Shokuhin Kk 新規清涼菓子およびその製造方法
TWI439288B (zh) * 2012-10-05 2014-06-01 Univ China Medical 藥用載體及其製備方法與用途
CA2885979A1 (fr) * 2012-10-11 2014-04-17 Theravida, Inc. Formulations pharmaceutiques de pilocarpine
WO2015167434A1 (fr) * 2014-04-28 2015-11-05 Eduardo Fernandez Compositions pour la supplémentation nutritionnelle
CN116159037B (zh) * 2023-04-25 2023-08-01 四川省川龙动科药业有限公司 一种防治仔猪结肠炎的靶向微丸组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197346B1 (en) * 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
US5985312A (en) * 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
WO2002005820A1 (fr) * 2000-07-19 2002-01-24 Lavipharm Laboratories, Inc. Dispersions solides de citrate de sildenafil ayant une forte solubilite dans l'eau
US6703045B2 (en) * 2001-08-21 2004-03-09 Council Of Scientific & Industrial Research Composition and method for maintaining blood glucose level

Also Published As

Publication number Publication date
AU2005285298A1 (en) 2006-03-23
WO2006031420A3 (fr) 2006-11-30
WO2006031420A2 (fr) 2006-03-23
EP1784167A2 (fr) 2007-05-16

Similar Documents

Publication Publication Date Title
US20080311191A1 (en) Multi-Layer Tablets and Bioadhesive Dosage Forms
US20080260824A1 (en) Bioadhesive Rate-Controlled Oral Dosage Formulations
US20100226855A1 (en) Rate-Controlled Oral Dosage Formulations
US9931405B2 (en) Pharmaceutical compositions for gastrointestinal drug delivery
CA2578845A1 (fr) Comprimes multicouche et formes posologiques bioadhesives
JP2008516893A (ja) 多層錠剤および生体接着性剤形
RU2385712C2 (ru) Рецептура с контролируемым высвобождением
US20070281007A1 (en) Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
AU2008282900B2 (en) Pulsatile gastric retentive dosage forms
Dehghan et al. Gastroretentive drug delivery systems: A patent perspective
US20080085306A1 (en) Topiramate compositions and methods of enhancing its bioavailability
US6881420B2 (en) Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
US20060045865A1 (en) Controlled regional oral delivery
US20020031552A1 (en) Teste masked pharmaceutical particles
US20060127478A1 (en) Oral dosage formulation
US8691272B2 (en) Multilayer tablet
EP2063867A2 (fr) Compositions pharmaceutiques pour le traitement de la maladie de parkinson et de troubles apparentés
CA2412024A1 (fr) Compositions et forme posologique pour liberation gastrique retardee d'alendronate et/ou d'autres bis-phosphonates
JP2003521507A (ja) ゼロ次薬物放出に接近するシェル−コア剤形
EP2034972A2 (fr) Particules à enrobage entérique contenant un ingrédient actif
US20110250238A1 (en) System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
US20120027855A1 (en) Pharmaceutical compositions for gastrointestinal drug delivery
NZ548844A (en) Controlled release pharmaceutical composition comprising an acid-insoluble polymer and bioadhesive polymer
WO2008074108A2 (fr) Composition pharmaceutique à libération contrôlée, forme pharmaceutique à libération contrôlée et procédé permettant l'obtention de la forme pharmaceutique

Legal Events

Date Code Title Description
FZDE Discontinued